Ibritumomab vs Anticoagulants

Interacting Drugs
Ibritumomab
vs
Anticoagulants
Security Level
Minor, Monitor Therapy
Mechanism
Anticoagulants: May enhance the adverse/toxic effect of Ibritumomab. Both agents may contribute to an increased risk of bleeding.
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Ibritumomab vs Anticoagulants


Other Interactions of Ibritumomab

We are Developing Our database, More results coming soon.

Other Interactions of Anticoagulants

We are Developing Our database, More results coming soon.